Hochschulschrift
Elucidation of the oncogenic EVI1 super-enhancer complex in inv(3)/t(3;3) leukemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
xxii, 121 Seiten
- Language
-
Englisch
- Notes
-
Illustrationen, Diagramme
Ruperto Carola University Heidelberg, Germany, Dissertation, 2021
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.03.2025, 11:51 AM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Time of origin
- [2021]
Other Objects (12)
Shared enhancer gene regulatory networks between wound and oncogenic programs
Oncogenic deregulation of cell adhesion molecules in leukemia
Characterization of the CD83 promoter, enhancer complex
Characterization of the CD83 promoter-enhancer complex : = Charakterisierung des CD83 Promotor-Enhancer- Komplexes
SMARCC1 controls oncogenic NOTCH1 signaling in T-cell acute lymphoblastic leukemia
Novel chromatin interactions by structural rearrangements and aberrant enhancer functions drive oncogenic programs in unfavorable neuroblastoma
Novel chromatin interactions by structural rearrangements and aberrant enhancer functions drive oncogenic programs in unfavorable neuroblastoma
The oncogenic role of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemia
Dissecting the role of lymphoid enhancer factor 1 (LEF1) in acute myeloid leukemia
Elucidation of mechanism of disease resistance and persistence in chronic myeloid leukemia
Elucidation of mechanism of disease resistance and persistence in chronic myeloid leukemia
Non-oncogene addiction of mixed-lineage Leukemia to CCAAT enhancer-binding proteins (C/EBPs)
Shared enhancer gene regulatory networks between wound and oncogenic programs
Oncogenic deregulation of cell adhesion molecules in leukemia
Characterization of the CD83 promoter, enhancer complex
Characterization of the CD83 promoter-enhancer complex : = Charakterisierung des CD83 Promotor-Enhancer- Komplexes
SMARCC1 controls oncogenic NOTCH1 signaling in T-cell acute lymphoblastic leukemia
Novel chromatin interactions by structural rearrangements and aberrant enhancer functions drive oncogenic programs in unfavorable neuroblastoma
Novel chromatin interactions by structural rearrangements and aberrant enhancer functions drive oncogenic programs in unfavorable neuroblastoma
The oncogenic role of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemia
Dissecting the role of lymphoid enhancer factor 1 (LEF1) in acute myeloid leukemia
Elucidation of mechanism of disease resistance and persistence in chronic myeloid leukemia
Elucidation of mechanism of disease resistance and persistence in chronic myeloid leukemia
Non-oncogene addiction of mixed-lineage Leukemia to CCAAT enhancer-binding proteins (C/EBPs)
Shared enhancer gene regulatory networks between wound and oncogenic programs
Oncogenic deregulation of cell adhesion molecules in leukemia
Characterization of the CD83 promoter, enhancer complex
Characterization of the CD83 promoter-enhancer complex : = Charakterisierung des CD83 Promotor-Enhancer- Komplexes
SMARCC1 controls oncogenic NOTCH1 signaling in T-cell acute lymphoblastic leukemia
Novel chromatin interactions by structural rearrangements and aberrant enhancer functions drive oncogenic programs in unfavorable neuroblastoma
Novel chromatin interactions by structural rearrangements and aberrant enhancer functions drive oncogenic programs in unfavorable neuroblastoma
The oncogenic role of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemia
Dissecting the role of lymphoid enhancer factor 1 (LEF1) in acute myeloid leukemia
Elucidation of mechanism of disease resistance and persistence in chronic myeloid leukemia
Elucidation of mechanism of disease resistance and persistence in chronic myeloid leukemia